Heron Therapeutics Inc (HRTX)

Operating Expenses

$116.80M

TTM · Period ending: · USD

HRTX logo

HRTX Operating Expenses

Latest reported$116.80M
HRTX TTM Operating Expenses (-$4.80M → $116.80M)
High-resolution chart · PNG

HRTX operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Heron Therapeutics Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
8,587,000
7,929,000
7,613,000
10,688,000
11,726,000
12,775,000
13,900,000
11,300,000
11,400,000
11,800,000
11,700,000
12,000,000
12,000,000
11,900,000
12,200,000
12,200,000
14,000,000
15,500,000
16,300,000
17,400,000
16,400,000
15,500,000
14,800,000
14,800,000
14,900,000
15,600,000
16,100,000
17,100,000
17,900,000
18,300,000
17,800,000
15,300,000
13,000,000
10,800,000
9,800,000
8,500,000
7,700,000
6,700,000
5,800,000
5,900,000
6,000,000
6,000,000
5,900,000
6,000,000
6,000,000
6,700,000
5,900,000
-4,100,000
-5,000,000
-6,800,000
-6,400,000
-3,800,000
-4,100,000
-4,200,000
-4,800,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.